Cebiotex en la American Society of Clinical Oncology 2021 Públicado en 11 junio 202129 julio 2022 por Cebiotex ASCO21: First-in-human administration of CEB-01, a novel drug delivery implant matrix, in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma (RPS) after surgery: Preliminary safety and pharmacokinetics report. Download poster Download abstract